nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—KIT—myenteric nerve plexus—rectum cancer	0.024	0.0425	CbGeAlD
Pazopanib—PDGFRA—penis—rectum cancer	0.017	0.0301	CbGeAlD
Pazopanib—MAP3K9—epithelium—rectum cancer	0.00887	0.0157	CbGeAlD
Pazopanib—MAP3K9—mammalian vulva—rectum cancer	0.0077	0.0136	CbGeAlD
Pazopanib—SH2B3—seminal vesicle—rectum cancer	0.00722	0.0128	CbGeAlD
Pazopanib—MAP3K9—female reproductive system—rectum cancer	0.00659	0.0117	CbGeAlD
Pazopanib—ITK—mammalian vulva—rectum cancer	0.00635	0.0112	CbGeAlD
Pazopanib—TAOK1—renal system—rectum cancer	0.00618	0.0109	CbGeAlD
Pazopanib—TAOK1—urethra—rectum cancer	0.00607	0.0108	CbGeAlD
Pazopanib—RIOK2—seminal vesicle—rectum cancer	0.00604	0.0107	CbGeAlD
Pazopanib—MAP3K9—vagina—rectum cancer	0.00596	0.0106	CbGeAlD
Pazopanib—TAOK1—mammalian vulva—rectum cancer	0.00578	0.0102	CbGeAlD
Pazopanib—SH2B3—urethra—rectum cancer	0.00571	0.0101	CbGeAlD
Pazopanib—SH2B3—mammalian vulva—rectum cancer	0.00544	0.00964	CbGeAlD
Pazopanib—STK36—seminal vesicle—rectum cancer	0.00543	0.00962	CbGeAlD
Pazopanib—PI4KB—seminal vesicle—rectum cancer	0.00535	0.00947	CbGeAlD
Pazopanib—FGFR3—epithelium—rectum cancer	0.00525	0.0093	CbGeAlD
Pazopanib—BMPR1B—epithelium—rectum cancer	0.0052	0.00921	CbGeAlD
Pazopanib—TAOK1—female reproductive system—rectum cancer	0.00495	0.00877	CbGeAlD
Pazopanib—ITK—vagina—rectum cancer	0.00492	0.00871	CbGeAlD
Pazopanib—FGFR3—renal system—rectum cancer	0.00487	0.00863	CbGeAlD
Pazopanib—FGFR3—urethra—rectum cancer	0.00478	0.00847	CbGeAlD
Pazopanib—RIOK2—urethra—rectum cancer	0.00478	0.00847	CbGeAlD
Pazopanib—PIP4K2C—seminal vesicle—rectum cancer	0.00469	0.00831	CbGeAlD
Pazopanib—AURKC—female reproductive system—rectum cancer	0.00459	0.00813	CbGeAlD
Pazopanib—FGFR3—mammalian vulva—rectum cancer	0.00455	0.00807	CbGeAlD
Pazopanib—RIOK2—mammalian vulva—rectum cancer	0.00455	0.00807	CbGeAlD
Pazopanib—TAOK1—vagina—rectum cancer	0.00448	0.00793	CbGeAlD
Pazopanib—PI4KB—smooth muscle tissue—rectum cancer	0.00447	0.00793	CbGeAlD
Pazopanib—PI4KB—renal system—rectum cancer	0.00431	0.00763	CbGeAlD
Pazopanib—STK36—urethra—rectum cancer	0.0043	0.00761	CbGeAlD
Pazopanib—PI4KB—urethra—rectum cancer	0.00423	0.0075	CbGeAlD
Pazopanib—SH2B3—vagina—rectum cancer	0.00421	0.00746	CbGeAlD
Pazopanib—PLK4—female reproductive system—rectum cancer	0.0042	0.00743	CbGeAlD
Pazopanib—FLT4—epithelium—rectum cancer	0.0041	0.00726	CbGeAlD
Pazopanib—STK36—mammalian vulva—rectum cancer	0.00409	0.00725	CbGeAlD
Pazopanib—PI4KB—mammalian vulva—rectum cancer	0.00403	0.00714	CbGeAlD
Pazopanib—STK16—female reproductive system—rectum cancer	0.00396	0.00702	CbGeAlD
Pazopanib—LIMK2—mammalian vulva—rectum cancer	0.00395	0.00701	CbGeAlD
Pazopanib—FGFR3—female reproductive system—rectum cancer	0.0039	0.00691	CbGeAlD
Pazopanib—RIOK2—female reproductive system—rectum cancer	0.0039	0.00691	CbGeAlD
Pazopanib—MAP3K19—female reproductive system—rectum cancer	0.00386	0.00684	CbGeAlD
Pazopanib—BMPR1B—female reproductive system—rectum cancer	0.00386	0.00684	CbGeAlD
Pazopanib—MAP3K9—lymph node—rectum cancer	0.00386	0.00683	CbGeAlD
Pazopanib—PIP4K2C—urethra—rectum cancer	0.00371	0.00658	CbGeAlD
Pazopanib—FGFR1—urethra—rectum cancer	0.00368	0.00652	CbGeAlD
Pazopanib—FLT1—seminal vesicle—rectum cancer	0.00367	0.0065	CbGeAlD
Pazopanib—FGF1—epithelium—rectum cancer	0.00364	0.00645	CbGeAlD
Pazopanib—EPHB6—seminal vesicle—rectum cancer	0.00362	0.00642	CbGeAlD
Pazopanib—STK16—vagina—rectum cancer	0.00358	0.00635	CbGeAlD
Pazopanib—PIP4K2C—mammalian vulva—rectum cancer	0.00353	0.00626	CbGeAlD
Pazopanib—RIOK2—vagina—rectum cancer	0.00353	0.00625	CbGeAlD
Pazopanib—FGF1—smooth muscle tissue—rectum cancer	0.00351	0.00621	CbGeAlD
Pazopanib—FGFR1—mammalian vulva—rectum cancer	0.00351	0.00621	CbGeAlD
Pazopanib—STK36—female reproductive system—rectum cancer	0.0035	0.00621	CbGeAlD
Pazopanib—TAOK3—seminal vesicle—rectum cancer	0.00346	0.00613	CbGeAlD
Pazopanib—PI4KB—female reproductive system—rectum cancer	0.00345	0.00611	CbGeAlD
Pazopanib—FGFR2—epithelium—rectum cancer	0.00344	0.00609	CbGeAlD
Pazopanib—LIMK2—female reproductive system—rectum cancer	0.00339	0.006	CbGeAlD
Pazopanib—FGF1—renal system—rectum cancer	0.00338	0.00598	CbGeAlD
Pazopanib—FGFR2—smooth muscle tissue—rectum cancer	0.00331	0.00587	CbGeAlD
Pazopanib—LCK—urethra—rectum cancer	0.0033	0.00584	CbGeAlD
Pazopanib—FGFR2—renal system—rectum cancer	0.00319	0.00565	CbGeAlD
Pazopanib—FLT1—epithelium—rectum cancer	0.00319	0.00564	CbGeAlD
Pazopanib—ITK—lymph node—rectum cancer	0.00318	0.00563	CbGeAlD
Pazopanib—STK36—vagina—rectum cancer	0.00317	0.00561	CbGeAlD
Pazopanib—LCK—mammalian vulva—rectum cancer	0.00314	0.00556	CbGeAlD
Pazopanib—PI4KB—vagina—rectum cancer	0.00312	0.00553	CbGeAlD
Pazopanib—KDR—seminal vesicle—rectum cancer	0.0031	0.00549	CbGeAlD
Pazopanib—MAP2K5—seminal vesicle—rectum cancer	0.0031	0.00549	CbGeAlD
Pazopanib—FLT1—smooth muscle tissue—rectum cancer	0.00307	0.00544	CbGeAlD
Pazopanib—LIMK2—vagina—rectum cancer	0.00306	0.00543	CbGeAlD
Pazopanib—FLT4—female reproductive system—rectum cancer	0.00304	0.00539	CbGeAlD
Pazopanib—PIP4K2C—female reproductive system—rectum cancer	0.00303	0.00536	CbGeAlD
Pazopanib—CSF1R—seminal vesicle—rectum cancer	0.00302	0.00536	CbGeAlD
Pazopanib—FLT1—renal system—rectum cancer	0.00295	0.00523	CbGeAlD
Pazopanib—FLT1—urethra—rectum cancer	0.0029	0.00514	CbGeAlD
Pazopanib—TAOK1—lymph node—rectum cancer	0.0029	0.00513	CbGeAlD
Pazopanib—PDGFRA—smooth muscle tissue—rectum cancer	0.00288	0.0051	CbGeAlD
Pazopanib—MAP3K2—female reproductive system—rectum cancer	0.00287	0.00508	CbGeAlD
Pazopanib—EPHB6—urethra—rectum cancer	0.00287	0.00508	CbGeAlD
Pazopanib—STK10—renal system—rectum cancer	0.0028	0.00495	CbGeAlD
Pazopanib—TAOK3—renal system—rectum cancer	0.00279	0.00494	CbGeAlD
Pazopanib—PDGFRA—renal system—rectum cancer	0.00277	0.0049	CbGeAlD
Pazopanib—FLT1—mammalian vulva—rectum cancer	0.00276	0.0049	CbGeAlD
Pazopanib—KIT—seminal vesicle—rectum cancer	0.00275	0.00487	CbGeAlD
Pazopanib—PIP4K2C—vagina—rectum cancer	0.00274	0.00485	CbGeAlD
Pazopanib—TAOK3—urethra—rectum cancer	0.00274	0.00485	CbGeAlD
Pazopanib—EPHB6—mammalian vulva—rectum cancer	0.00273	0.00484	CbGeAlD
Pazopanib—SH2B3—lymph node—rectum cancer	0.00273	0.00483	CbGeAlD
Pazopanib—FGFR1—vagina—rectum cancer	0.00272	0.00481	CbGeAlD
Pazopanib—FGF1—female reproductive system—rectum cancer	0.0027	0.00479	CbGeAlD
Pazopanib—KDR—epithelium—rectum cancer	0.00269	0.00477	CbGeAlD
Pazopanib—AURKC—lymph node—rectum cancer	0.00268	0.00475	CbGeAlD
Pazopanib—PDGFRB—seminal vesicle—rectum cancer	0.00268	0.00475	CbGeAlD
Pazopanib—UGT1A1—renal system—rectum cancer	0.00264	0.00468	CbGeAlD
Pazopanib—STK10—mammalian vulva—rectum cancer	0.00262	0.00463	CbGeAlD
Pazopanib—TAOK3—mammalian vulva—rectum cancer	0.00261	0.00462	CbGeAlD
Pazopanib—KDR—smooth muscle tissue—rectum cancer	0.00259	0.0046	CbGeAlD
Pazopanib—FGFR2—female reproductive system—rectum cancer	0.00255	0.00452	CbGeAlD
Pazopanib—CSF1R—smooth muscle tissue—rectum cancer	0.00253	0.00449	CbGeAlD
Pazopanib—KDR—renal system—rectum cancer	0.0025	0.00442	CbGeAlD
Pazopanib—PLK4—lymph node—rectum cancer	0.00245	0.00435	CbGeAlD
Pazopanib—KDR—urethra—rectum cancer	0.00245	0.00435	CbGeAlD
Pazopanib—MAP2K5—urethra—rectum cancer	0.00245	0.00435	CbGeAlD
Pazopanib—LCK—vagina—rectum cancer	0.00243	0.0043	CbGeAlD
Pazopanib—CSF1R—urethra—rectum cancer	0.00239	0.00424	CbGeAlD
Pazopanib—KIT—epithelium—rectum cancer	0.00239	0.00423	CbGeAlD
Pazopanib—FLT1—female reproductive system—rectum cancer	0.00237	0.00419	CbGeAlD
Pazopanib—KDR—mammalian vulva—rectum cancer	0.00234	0.00414	CbGeAlD
Pazopanib—MAP2K5—mammalian vulva—rectum cancer	0.00234	0.00414	CbGeAlD
Pazopanib—PDGFRB—epithelium—rectum cancer	0.00233	0.00413	CbGeAlD
Pazopanib—STK16—lymph node—rectum cancer	0.00232	0.00411	CbGeAlD
Pazopanib—KIT—smooth muscle tissue—rectum cancer	0.0023	0.00407	CbGeAlD
Pazopanib—RIOK2—lymph node—rectum cancer	0.00228	0.00404	CbGeAlD
Pazopanib—CSF1R—mammalian vulva—rectum cancer	0.00228	0.00404	CbGeAlD
Pazopanib—BMPR1B—lymph node—rectum cancer	0.00226	0.004	CbGeAlD
Pazopanib—PDGFRB—smooth muscle tissue—rectum cancer	0.00225	0.00398	CbGeAlD
Pazopanib—STK10—female reproductive system—rectum cancer	0.00224	0.00397	CbGeAlD
Pazopanib—TAOK3—female reproductive system—rectum cancer	0.00223	0.00395	CbGeAlD
Pazopanib—PDGFRA—female reproductive system—rectum cancer	0.00222	0.00393	CbGeAlD
Pazopanib—KIT—renal system—rectum cancer	0.00221	0.00392	CbGeAlD
Pazopanib—SLCO1B1—renal system—rectum cancer	0.0022	0.00389	CbGeAlD
Pazopanib—KIT—urethra—rectum cancer	0.00217	0.00385	CbGeAlD
Pazopanib—PDGFRB—renal system—rectum cancer	0.00216	0.00383	CbGeAlD
Pazopanib—FLT1—vagina—rectum cancer	0.00214	0.00379	CbGeAlD
Pazopanib—PDGFRB—urethra—rectum cancer	0.00212	0.00376	CbGeAlD
Pazopanib—EPHB6—vagina—rectum cancer	0.00212	0.00375	CbGeAlD
Pazopanib—KIT—mammalian vulva—rectum cancer	0.00207	0.00367	CbGeAlD
Pazopanib—STK36—lymph node—rectum cancer	0.00205	0.00363	CbGeAlD
Pazopanib—STK10—vagina—rectum cancer	0.00203	0.00359	CbGeAlD
Pazopanib—PDGFRB—mammalian vulva—rectum cancer	0.00202	0.00358	CbGeAlD
Pazopanib—TAOK3—vagina—rectum cancer	0.00202	0.00358	CbGeAlD
Pazopanib—PI4KB—lymph node—rectum cancer	0.00202	0.00357	CbGeAlD
Pazopanib—PDGFRA—vagina—rectum cancer	0.00201	0.00355	CbGeAlD
Pazopanib—KDR—female reproductive system—rectum cancer	0.002	0.00354	CbGeAlD
Pazopanib—MAP2K5—female reproductive system—rectum cancer	0.002	0.00354	CbGeAlD
Pazopanib—LIMK2—lymph node—rectum cancer	0.00198	0.00351	CbGeAlD
Pazopanib—CSF1R—female reproductive system—rectum cancer	0.00195	0.00346	CbGeAlD
Pazopanib—KDR—vagina—rectum cancer	0.00181	0.0032	CbGeAlD
Pazopanib—MAP2K5—vagina—rectum cancer	0.00181	0.0032	CbGeAlD
Pazopanib—FLT4—lymph node—rectum cancer	0.00178	0.00315	CbGeAlD
Pazopanib—KIT—female reproductive system—rectum cancer	0.00177	0.00314	CbGeAlD
Pazopanib—PIP4K2C—lymph node—rectum cancer	0.00177	0.00314	CbGeAlD
Pazopanib—CSF1R—vagina—rectum cancer	0.00177	0.00313	CbGeAlD
Pazopanib—SLCO1B1—female reproductive system—rectum cancer	0.00176	0.00312	CbGeAlD
Pazopanib—FGFR1—lymph node—rectum cancer	0.00176	0.00311	CbGeAlD
Pazopanib—PDGFRB—female reproductive system—rectum cancer	0.00173	0.00307	CbGeAlD
Pazopanib—MAP3K2—lymph node—rectum cancer	0.00168	0.00297	CbGeAlD
Pazopanib—KIT—vagina—rectum cancer	0.0016	0.00284	CbGeAlD
Pazopanib—FGF1—lymph node—rectum cancer	0.00158	0.0028	CbGeAlD
Pazopanib—LCK—lymph node—rectum cancer	0.00157	0.00278	CbGeAlD
Pazopanib—PDGFRB—vagina—rectum cancer	0.00157	0.00277	CbGeAlD
Pazopanib—ABCG2—seminal vesicle—rectum cancer	0.00151	0.00267	CbGeAlD
Pazopanib—FLT1—lymph node—rectum cancer	0.00138	0.00245	CbGeAlD
Pazopanib—EPHB6—lymph node—rectum cancer	0.00137	0.00242	CbGeAlD
Pazopanib—STK10—lymph node—rectum cancer	0.00131	0.00232	CbGeAlD
Pazopanib—TAOK3—lymph node—rectum cancer	0.00131	0.00231	CbGeAlD
Pazopanib—PDGFRA—lymph node—rectum cancer	0.0013	0.0023	CbGeAlD
Pazopanib—CYP2C8—renal system—rectum cancer	0.00125	0.00221	CbGeAlD
Pazopanib—ABCG2—urethra—rectum cancer	0.00119	0.00211	CbGeAlD
Pazopanib—MAP2K5—lymph node—rectum cancer	0.00117	0.00207	CbGeAlD
Pazopanib—KDR—lymph node—rectum cancer	0.00117	0.00207	CbGeAlD
Pazopanib—CYP1A2—renal system—rectum cancer	0.00117	0.00207	CbGeAlD
Pazopanib—CSF1R—lymph node—rectum cancer	0.00114	0.00202	CbGeAlD
Pazopanib—ABCG2—mammalian vulva—rectum cancer	0.00114	0.00201	CbGeAlD
Pazopanib—KIT—lymph node—rectum cancer	0.00104	0.00184	CbGeAlD
Pazopanib—PDGFRB—lymph node—rectum cancer	0.00101	0.00179	CbGeAlD
Pazopanib—CYP2C8—female reproductive system—rectum cancer	0.001	0.00177	CbGeAlD
Pazopanib—CYP2C8—vagina—rectum cancer	0.000905	0.0016	CbGeAlD
Pazopanib—ABCG2—vagina—rectum cancer	0.00088	0.00156	CbGeAlD
Pazopanib—CYP3A4—renal system—rectum cancer	0.000846	0.0015	CbGeAlD
Pazopanib—CYP2D6—renal system—rectum cancer	0.000833	0.00148	CbGeAlD
Pazopanib—ABCB1—seminal vesicle—rectum cancer	0.000744	0.00132	CbGeAlD
Pazopanib—CYP3A4—female reproductive system—rectum cancer	0.000678	0.0012	CbGeAlD
Pazopanib—CYP2D6—female reproductive system—rectum cancer	0.000667	0.00118	CbGeAlD
Pazopanib—ABCB1—epithelium—rectum cancer	0.000646	0.00114	CbGeAlD
Pazopanib—ABCB1—renal system—rectum cancer	0.000599	0.00106	CbGeAlD
Pazopanib—ABCB1—urethra—rectum cancer	0.000589	0.00104	CbGeAlD
Pazopanib—ABCG2—lymph node—rectum cancer	0.000569	0.00101	CbGeAlD
Pazopanib—ABCB1—mammalian vulva—rectum cancer	0.00056	0.000993	CbGeAlD
Pazopanib—ABCB1—female reproductive system—rectum cancer	0.00048	0.00085	CbGeAlD
Pazopanib—ABCB1—vagina—rectum cancer	0.000434	0.000769	CbGeAlD
Pazopanib—ABCB1—lymph node—rectum cancer	0.000281	0.000497	CbGeAlD
Pazopanib—LCK—Signaling by SCF-KIT—HRAS—rectum cancer	0.000172	0.000394	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—NRAS—rectum cancer	0.000171	0.000393	CbGpPWpGaD
Pazopanib—ITK—Immune System—NRAS—rectum cancer	0.000171	0.000392	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—KRAS—rectum cancer	0.000171	0.000392	CbGpPWpGaD
Pazopanib—PDGFRB—Focal Adhesion—HRAS—rectum cancer	0.000168	0.000387	CbGpPWpGaD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.000168	0.000386	CbGpPWpGaD
Pazopanib—LCK—DAP12 interactions—KRAS—rectum cancer	0.000168	0.000386	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR in disease—KRAS—rectum cancer	0.000168	0.000386	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—KRAS—rectum cancer	0.000168	0.000385	CbGpPWpGaD
Pazopanib—FGFR1—Axon guidance—NRAS—rectum cancer	0.000167	0.000384	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—KRAS—rectum cancer	0.000167	0.000383	CbGpPWpGaD
Pazopanib—KDR—Axon guidance—HRAS—rectum cancer	0.000166	0.000382	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—NRAS—rectum cancer	0.000166	0.000381	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000165	0.00038	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—NRAS—rectum cancer	0.000165	0.00038	CbGpPWpGaD
Pazopanib—PDGFRB—B Cell Activation—HRAS—rectum cancer	0.000165	0.000379	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—KRAS—rectum cancer	0.000165	0.000378	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—NRAS—rectum cancer	0.000164	0.000377	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000164	0.000377	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—NRAS—rectum cancer	0.000162	0.000372	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB4—HRAS—rectum cancer	0.000162	0.000371	CbGpPWpGaD
Pazopanib—LYN—B Cell Activation—HRAS—rectum cancer	0.000162	0.000371	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—KRAS—rectum cancer	0.000159	0.000365	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—KRAS—rectum cancer	0.000159	0.000364	CbGpPWpGaD
Pazopanib—PDGFRB—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000158	0.000363	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—NRAS—rectum cancer	0.000158	0.000362	CbGpPWpGaD
Pazopanib—LCK—B Cell Activation—KRAS—rectum cancer	0.000156	0.000358	CbGpPWpGaD
Pazopanib—LCK—Downstream signal transduction—HRAS—rectum cancer	0.000154	0.000354	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR—HRAS—rectum cancer	0.000154	0.000353	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB2—HRAS—rectum cancer	0.000153	0.000351	CbGpPWpGaD
Pazopanib—LCK—DAP12 signaling—HRAS—rectum cancer	0.000152	0.000349	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.00015	0.000344	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000149	0.000342	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—KRAS—rectum cancer	0.000147	0.000339	CbGpPWpGaD
Pazopanib—LYN—Axon guidance—NRAS—rectum cancer	0.000147	0.000338	CbGpPWpGaD
Pazopanib—ITK—Immune System—KRAS—rectum cancer	0.000147	0.000338	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—HRAS—rectum cancer	0.000145	0.000333	CbGpPWpGaD
Pazopanib—FGFR1—Axon guidance—KRAS—rectum cancer	0.000144	0.00033	CbGpPWpGaD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000143	0.000329	CbGpPWpGaD
Pazopanib—LCK—DAP12 interactions—HRAS—rectum cancer	0.000143	0.000329	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR in disease—HRAS—rectum cancer	0.000143	0.000329	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—KRAS—rectum cancer	0.000143	0.000328	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—HRAS—rectum cancer	0.000142	0.000327	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—KRAS—rectum cancer	0.000142	0.000327	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—HRAS—rectum cancer	0.000142	0.000326	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—KRAS—rectum cancer	0.000141	0.000325	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000141	0.000323	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—HRAS—rectum cancer	0.00014	0.000321	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—KRAS—rectum cancer	0.00014	0.00032	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—NRAS—rectum cancer	0.000137	0.000314	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—KRAS—rectum cancer	0.000136	0.000312	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—NRAS—rectum cancer	0.000136	0.000311	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—HRAS—rectum cancer	0.000135	0.00031	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—HRAS—rectum cancer	0.000135	0.00031	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—NRAS—rectum cancer	0.000133	0.000306	CbGpPWpGaD
Pazopanib—LCK—B Cell Activation—HRAS—rectum cancer	0.000132	0.000304	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—NRAS—rectum cancer	0.000131	0.000301	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—TP53—rectum cancer	0.000131	0.000301	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000127	0.000291	CbGpPWpGaD
Pazopanib—LYN—Axon guidance—KRAS—rectum cancer	0.000127	0.000291	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—HRAS—rectum cancer	0.000125	0.000288	CbGpPWpGaD
Pazopanib—ITK—Immune System—HRAS—rectum cancer	0.000125	0.000287	CbGpPWpGaD
Pazopanib—FGFR1—Axon guidance—HRAS—rectum cancer	0.000122	0.000281	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—HRAS—rectum cancer	0.000121	0.000279	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—HRAS—rectum cancer	0.000121	0.000278	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—HRAS—rectum cancer	0.00012	0.000276	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—NRAS—rectum cancer	0.000119	0.000274	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—NRAS—rectum cancer	0.000119	0.000273	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—HRAS—rectum cancer	0.000119	0.000272	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—KRAS—rectum cancer	0.000118	0.00027	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—KRAS—rectum cancer	0.000117	0.000268	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—HRAS—rectum cancer	0.000115	0.000265	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—KRAS—rectum cancer	0.000115	0.000263	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—NRAS—rectum cancer	0.000113	0.00026	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—KRAS—rectum cancer	0.000113	0.000259	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—NRAS—rectum cancer	0.000111	0.000255	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—NRAS—rectum cancer	0.000109	0.000249	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—NRAS—rectum cancer	0.000109	0.000249	CbGpPWpGaD
Pazopanib—LYN—Axon guidance—HRAS—rectum cancer	0.000108	0.000247	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—NRAS—rectum cancer	0.000107	0.000245	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—NRAS—rectum cancer	0.000105	0.000242	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—NRAS—rectum cancer	0.000105	0.000241	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—NRAS—rectum cancer	0.000105	0.000241	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—NRAS—rectum cancer	0.000103	0.000236	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—KRAS—rectum cancer	0.000103	0.000236	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—KRAS—rectum cancer	0.000102	0.000235	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—NRAS—rectum cancer	0.000101	0.000232	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—NRAS—rectum cancer	0.000101	0.000232	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—HRAS—rectum cancer	9.99e-05	0.000229	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—HRAS—rectum cancer	9.91e-05	0.000228	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—HRAS—rectum cancer	9.75e-05	0.000224	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—KRAS—rectum cancer	9.73e-05	0.000223	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—HRAS—rectum cancer	9.6e-05	0.00022	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—NRAS—rectum cancer	9.57e-05	0.00022	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—KRAS—rectum cancer	9.56e-05	0.000219	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—NRAS—rectum cancer	9.47e-05	0.000217	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—KRAS—rectum cancer	9.35e-05	0.000215	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—KRAS—rectum cancer	9.34e-05	0.000215	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—NRAS—rectum cancer	9.27e-05	0.000213	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—KRAS—rectum cancer	9.18e-05	0.000211	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—NRAS—rectum cancer	9.09e-05	0.000209	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—TP53—rectum cancer	9.09e-05	0.000209	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—KRAS—rectum cancer	9.07e-05	0.000208	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—KRAS—rectum cancer	9.05e-05	0.000208	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—KRAS—rectum cancer	9.03e-05	0.000207	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—TYMS—rectum cancer	9.01e-05	0.000207	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—NRAS—rectum cancer	8.9e-05	0.000204	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—KRAS—rectum cancer	8.86e-05	0.000203	CbGpPWpGaD
Pazopanib—FGFR3—Disease—NRAS—rectum cancer	8.84e-05	0.000203	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—HRAS—rectum cancer	8.73e-05	0.0002	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—KRAS—rectum cancer	8.71e-05	0.0002	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—HRAS—rectum cancer	8.69e-05	0.0002	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—KRAS—rectum cancer	8.69e-05	0.000199	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—NRAS—rectum cancer	8.44e-05	0.000194	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—TP53—rectum cancer	8.31e-05	0.000191	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	8.3e-05	0.00019	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—HRAS—rectum cancer	8.27e-05	0.00019	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—TYMS—rectum cancer	8.26e-05	0.00019	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—KRAS—rectum cancer	8.24e-05	0.000189	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—KRAS—rectum cancer	8.15e-05	0.000187	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—HRAS—rectum cancer	8.12e-05	0.000187	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—NRAS—rectum cancer	8.1e-05	0.000186	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—KRAS—rectum cancer	7.98e-05	0.000183	CbGpPWpGaD
Pazopanib—FGF1—Immune System—NRAS—rectum cancer	7.96e-05	0.000183	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—HRAS—rectum cancer	7.95e-05	0.000182	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—HRAS—rectum cancer	7.94e-05	0.000182	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—TP53—rectum cancer	7.88e-05	0.000181	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—KRAS—rectum cancer	7.83e-05	0.00018	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—HRAS—rectum cancer	7.8e-05	0.000179	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—HRAS—rectum cancer	7.71e-05	0.000177	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—HRAS—rectum cancer	7.69e-05	0.000177	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—HRAS—rectum cancer	7.68e-05	0.000176	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—KRAS—rectum cancer	7.66e-05	0.000176	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—TYMS—rectum cancer	7.65e-05	0.000176	CbGpPWpGaD
Pazopanib—FGFR3—Disease—KRAS—rectum cancer	7.61e-05	0.000175	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—NRAS—rectum cancer	7.6e-05	0.000174	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—HRAS—rectum cancer	7.53e-05	0.000173	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—HRAS—rectum cancer	7.4e-05	0.00017	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—HRAS—rectum cancer	7.38e-05	0.00017	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	7.37e-05	0.000169	CbGpPWpGaD
Pazopanib—FGF1—Disease—NRAS—rectum cancer	7.35e-05	0.000169	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—NRAS—rectum cancer	7.3e-05	0.000168	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—KRAS—rectum cancer	7.26e-05	0.000167	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—HRAS—rectum cancer	7e-05	0.000161	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—KRAS—rectum cancer	6.98e-05	0.00016	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—HRAS—rectum cancer	6.93e-05	0.000159	CbGpPWpGaD
Pazopanib—FGF1—Immune System—KRAS—rectum cancer	6.85e-05	0.000157	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—HRAS—rectum cancer	6.78e-05	0.000156	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—HRAS—rectum cancer	6.65e-05	0.000153	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—NRAS—rectum cancer	6.58e-05	0.000151	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—KRAS—rectum cancer	6.54e-05	0.00015	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—HRAS—rectum cancer	6.51e-05	0.00015	CbGpPWpGaD
Pazopanib—KIT—Immune System—NRAS—rectum cancer	6.47e-05	0.000148	CbGpPWpGaD
Pazopanib—FGFR3—Disease—HRAS—rectum cancer	6.47e-05	0.000148	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—rectum cancer	6.46e-05	0.000148	CbGpPWpGaD
Pazopanib—FGF1—Disease—KRAS—rectum cancer	6.32e-05	0.000145	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—KRAS—rectum cancer	6.28e-05	0.000144	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—rectum cancer	6.2e-05	0.000142	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—NRAS—rectum cancer	6.19e-05	0.000142	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—HRAS—rectum cancer	6.17e-05	0.000142	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—NRAS—rectum cancer	6.14e-05	0.000141	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—NRAS—rectum cancer	6.12e-05	0.000141	CbGpPWpGaD
Pazopanib—FGFR2—Disease—NRAS—rectum cancer	6.08e-05	0.00014	CbGpPWpGaD
Pazopanib—KIT—Disease—NRAS—rectum cancer	5.97e-05	0.000137	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—HRAS—rectum cancer	5.93e-05	0.000136	CbGpPWpGaD
Pazopanib—FGF1—Immune System—HRAS—rectum cancer	5.82e-05	0.000134	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—KRAS—rectum cancer	5.67e-05	0.00013	CbGpPWpGaD
Pazopanib—FGFR1—Disease—NRAS—rectum cancer	5.67e-05	0.00013	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—NRAS—rectum cancer	5.65e-05	0.00013	CbGpPWpGaD
Pazopanib—KIT—Immune System—KRAS—rectum cancer	5.57e-05	0.000128	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—HRAS—rectum cancer	5.56e-05	0.000128	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—NRAS—rectum cancer	5.53e-05	0.000127	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NRAS—rectum cancer	5.51e-05	0.000127	CbGpPWpGaD
Pazopanib—LYN—Immune System—NRAS—rectum cancer	5.4e-05	0.000124	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—NRAS—rectum cancer	5.39e-05	0.000124	CbGpPWpGaD
Pazopanib—FGF1—Disease—HRAS—rectum cancer	5.37e-05	0.000123	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—HRAS—rectum cancer	5.34e-05	0.000123	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—KRAS—rectum cancer	5.33e-05	0.000122	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—KRAS—rectum cancer	5.28e-05	0.000121	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—KRAS—rectum cancer	5.27e-05	0.000121	CbGpPWpGaD
Pazopanib—FGFR2—Disease—KRAS—rectum cancer	5.23e-05	0.00012	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NRAS—rectum cancer	5.14e-05	0.000118	CbGpPWpGaD
Pazopanib—KIT—Disease—KRAS—rectum cancer	5.14e-05	0.000118	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NRAS—rectum cancer	5.09e-05	0.000117	CbGpPWpGaD
Pazopanib—FGFR1—Disease—KRAS—rectum cancer	4.88e-05	0.000112	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—KRAS—rectum cancer	4.86e-05	0.000112	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HRAS—rectum cancer	4.82e-05	0.000111	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—KRAS—rectum cancer	4.76e-05	0.000109	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—KRAS—rectum cancer	4.75e-05	0.000109	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TYMS—rectum cancer	4.74e-05	0.000109	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—rectum cancer	4.73e-05	0.000109	CbGpPWpGaD
Pazopanib—KIT—Immune System—HRAS—rectum cancer	4.73e-05	0.000109	CbGpPWpGaD
Pazopanib—LYN—Immune System—KRAS—rectum cancer	4.65e-05	0.000107	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—KRAS—rectum cancer	4.64e-05	0.000107	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HRAS—rectum cancer	4.53e-05	0.000104	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HRAS—rectum cancer	4.49e-05	0.000103	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HRAS—rectum cancer	4.48e-05	0.000103	CbGpPWpGaD
Pazopanib—FGFR2—Disease—HRAS—rectum cancer	4.45e-05	0.000102	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KRAS—rectum cancer	4.43e-05	0.000102	CbGpPWpGaD
Pazopanib—LCK—Immune System—NRAS—rectum cancer	4.43e-05	0.000102	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—KRAS—rectum cancer	4.38e-05	0.000101	CbGpPWpGaD
Pazopanib—KIT—Disease—HRAS—rectum cancer	4.37e-05	0.0001	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NRAS—rectum cancer	4.26e-05	9.78e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—rectum cancer	4.23e-05	9.72e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NRAS—rectum cancer	4.18e-05	9.6e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HRAS—rectum cancer	4.15e-05	9.52e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HRAS—rectum cancer	4.13e-05	9.49e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TYMS—rectum cancer	4.13e-05	9.49e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—rectum cancer	4.12e-05	9.47e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NRAS—rectum cancer	4.09e-05	9.38e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HRAS—rectum cancer	4.05e-05	9.29e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HRAS—rectum cancer	4.03e-05	9.26e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NRAS—rectum cancer	3.97e-05	9.11e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NRAS—rectum cancer	3.96e-05	9.09e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—HRAS—rectum cancer	3.95e-05	9.07e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HRAS—rectum cancer	3.94e-05	9.06e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—rectum cancer	3.94e-05	9.04e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TYMS—rectum cancer	3.9e-05	8.94e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—KRAS—rectum cancer	3.81e-05	8.75e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HRAS—rectum cancer	3.76e-05	8.64e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HRAS—rectum cancer	3.72e-05	8.55e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KRAS—rectum cancer	3.66e-05	8.41e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—KRAS—rectum cancer	3.6e-05	8.26e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NRAS—rectum cancer	3.57e-05	8.19e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—KRAS—rectum cancer	3.52e-05	8.08e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NRAS—rectum cancer	3.49e-05	8.02e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KRAS—rectum cancer	3.42e-05	7.84e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KRAS—rectum cancer	3.41e-05	7.82e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TYMS—rectum cancer	3.3e-05	7.58e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—rectum cancer	3.26e-05	7.48e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—HRAS—rectum cancer	3.24e-05	7.43e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—rectum cancer	3.2e-05	7.34e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HRAS—rectum cancer	3.11e-05	7.15e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KRAS—rectum cancer	3.07e-05	7.05e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HRAS—rectum cancer	3.06e-05	7.02e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—rectum cancer	3.04e-05	6.97e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—rectum cancer	3.03e-05	6.95e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KRAS—rectum cancer	3e-05	6.9e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—HRAS—rectum cancer	2.99e-05	6.86e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HRAS—rectum cancer	2.9e-05	6.67e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HRAS—rectum cancer	2.9e-05	6.65e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NRAS—rectum cancer	2.86e-05	6.57e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—rectum cancer	2.73e-05	6.26e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—rectum cancer	2.67e-05	6.13e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HRAS—rectum cancer	2.61e-05	5.99e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HRAS—rectum cancer	2.55e-05	5.86e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TYMS—rectum cancer	2.55e-05	5.85e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KRAS—rectum cancer	2.46e-05	5.65e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—rectum cancer	2.19e-05	5.03e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HRAS—rectum cancer	2.09e-05	4.81e-05	CbGpPWpGaD
